Mind Medicine (MNMD) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts MNMD Hot Sheet
Join SI Premium – FREE
Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.76), $0.23 worse than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Mind Medicine (MNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Southland Holdings (SLND) Misses Q2 EPS by 122c
- Gaxos.ai Inc. (GXAI) Reports Q2 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
